Guess I just need to file this one away and forget about it for a while. I certainly can't fight the massive market manipulation that is underway.
Please educate me because what I see is a stock that peaked on March 5 at $21.13/share and now sits at $12.75/share -- a loss of 40%.
My argument in my post was that there doesn't seem to be support at any level, and the 40% decline in RGLS supports that thesis. Further, my argument was that the manipulation of Biotech stocks was irrelevant of fundamentals, outlook, prospects, etc., and was not stock specific. So please, fill in the missing blanks that shows me there IS in fact support for stocks like RGLS, and maybe it is going up instead of 40% down.
I am open to learn, so have at it.
That is the real underlying value. It's as if there was a blip on the Apple Watch. It is such a tiny part of their sales, it would be inconsequential, although headline-grabbing to be sure. This is much ado about nothing.
Not only that, I wouldn't hesitate to buy LL products/flooring and put them in my own home - and sleep on them face down!
I stand by my call that ISIS is at a bottom. A week/month/year from now it will be higher, much higher. A year from now - DOUBLE.
Really? I thought I was looking kinda smart ...
I think people are wary, nothing more. They are careful, but therein lies the problem. The slam story by the media-junkie was very damaging because it cast a lot of doubt Nd raised questions that are very hard for anyone to answer.
A lot like a school principal accused of inappropriate behavior - it is such a sticky situation, the allegation alone is damaging. Even if completely unfounded.
CLDX posted a good quarter and that stock should rebound nicely. SCMP is a much better investment though and a month from now should be far ahead of all others on a comparative percentage valuation.
While I'm not sure what triggered the sell off to begin with, they posted good numbers and a nice Quarter. Should rebound from here well.
Ignore those that pretend LL is way overvalued, because clearly it is not. Only a small percentage of the flooring is in question. I will wait solely based on the DOJ probe because nothing this government administration touches - is good. The only question is how bad it will be and for how long.
Ideally, the government will be thorough and come back and say LL is squeaky clean. That would boost shares 50% or more overnight. But it will take time for that to happen, and during that time, the shorts will have their way.
But shorts should be very very careful. A strategy change by the company, or govt vindication could cause a major gap up instantly, and there will be no recovery for shorts then.
While the DOJ probe may ultimately vindicate LL and prove conclusively they are clean, nothing much good ever comes with these kind of dealings with the government. Very dangerous and expensive.
Good luck to LL longs. I'll check back later to buy on a dip.
This appears to be the bottom. I never thought this stock would ever dip below $60 again, this should rebound from here.
An interview on CNBC an analyst said:
Traders have hammered biotech stocks, with the IBB, the iShares ETF that tracks the sector, losing 5 percent in the last two sessions. But rather than run from the selling, one trader who relies heavily on the charts is diving in.
According to Andrew Keene of Keene on the Market, the IBB had found "support" at its current levels. Looking at both a weekly and a daily chart of the biotech index, Keene noted that the IBB has responded particularly well when it has touched its 50-day moving average.
"We saw buyers back in April," said Keene, referring to the 50-day average, which comes into play at around $348. "And we saw buyers in February and December," when the index also touched that key technical level. Keene also said that the IBB hasn't touched its 100-day moving average since last October. With the IBB above both its 50- and hundred-day moving average at $350, Keene's plan is simple.
"Buy the pullbacks—any pullbacks whatsoever," said Keene. "This stock, on the daily chart and on the weekly chart, it lines up for buy opportunity."
I guess it isn't that hard to pass a stationary object that isn't making any progress. At least with the CEO replaced there is some hope they can move forward.
Merck, Pfizer, others, all beating to the upside, but a massive selloff across the Biotech sector, from 5-20% gone in a few days for no reason, other than market manipulation.
Wasn't Obama going to clean all this #$%$ up?
This is nothing more than market manipulation, with all biotechs selling off, then a big surge coming in May to return them back to where they were before the artificial pullback. ISIS looks as good as ever.
All the biotech stocks are pulling back ahead of earnings. At earnings announcement they will "surge" and return to where they were a week or two ago on the great earnings beats. However, this is nothing more than market manipulation at its finest.
That way a big "surge" of 10% on the great earnings news - is nothing more than returning to the levels it was before the artificial drawback.
Uh, ok, not sure what your post has to do with my post ... But OK.
Prince - go easy on him - that short position must be absolutely KILLING him.